772
Views
0
CrossRef citations to date
0
Altmetric
Articles

Homozygous iMycCα transgenic mice as a model of plasma B-cell lymphomas

, , , , , , & show all
Pages 2114-2125 | Received 17 Jan 2022, Accepted 06 Apr 2022, Published online: 28 Apr 2022

References

  • Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104(10):3009–3020.
  • Saintamand A, Rouaud P, Garot A, et al. The IgH 3' regulatory region governs μ chain transcription in mature B lymphocytes and the B cell fate. Oncotarget. 2015;6(7):4845–4852.
  • Saintamand A, Rouaud P, Saad F, et al. Elucidation of IgH 3' region regulatory role during class switch recombination via germline deletion. Nat Commun. 2015;6:7084.
  • Péron S, Laffleur B, Denis-Lagache N, et al. AID-driven deletion causes immunoglobulin heavy chain “locus suicide recombination” in B cells. Science. 2012;336(6083):931–934.
  • Rouaud P, Vincent-Fabert C, Saintamand A, et al. The IgH 3' regulatory region controls somatic hypermutation in germinal center B cells. J Exp Med. 2013;210(8):1501–1507.
  • Rouaud P, Vincent-Fabert C, Fiancette R, et al. Enhancers located in heavy chain regulatory region (hs3a, hs1,2, hs3b, and hs4) are dispensable for diversity of VDJ recombination. J Biol Chem. 2012;287(11):8356–8360.
  • Rosean TR, Holman CJ, Tompkins VS, et al. KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic neoplasms in mice. Blood Cancer J. 2016;6:e398.
  • Park SS, Kim JS, Tessarollo L, et al. Insertion of c-Myc into igh induces B-cell and plasma-cell neoplasms in mice. Cancer Res. 2005;65(4):1306–1315.
  • Cheung WC, Kim JS, Linden M, et al. Novel targeted deregulation of c-myc cooperates with Bcl-XL to cause plasma cell neoplasms in mice. J Clin Invest. 2004;113(12):1763–1773.
  • Ghazzaui N, Issaoui H, Ferrad M, et al. Eμ and 3'RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomas. Blood Adv. 2020;4(1):28–39.
  • Ferrad M, Ghazzaui N, Issaoui H, et al. Mouse models of c-myc deregulation driven by IgH locus enhancers as models of B-cell lymphomagenesis. Frontiers Immunol. 2020;11:1564.
  • Jovanović KK, Roche-Lestienne C, Ghobrial IM, et al. Targeting MYC in multiple myeloma. Leukemia. 2018;32(6):1295–1306.
  • Vincent-Fabert C, Fiancette R, Pinaud E, et al. Genomic deletion of the whole IgH 3' regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypes. Blood. 2010;116(11):1895–1898.
  • Wingett SW, Andrews S. FastQ screen: a tool for multi-genome mapping and quality control. F1000Res. 2018;7:1338.
  • Chen S, Zhou Y, Chen Y, et al. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884–i890.
  • Ewels P, Magnusson M, Lundin S, et al. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32(19):3047–3048.
  • Patro R, Duggal G, Love MI, et al. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14(4):417–419.
  • Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.
  • Issaoui H, Ghazzaui N, Saintamand A, et al. The IgH 3' regulatory region super-enhancer does not control IgA class switch recombination in the B1 lineage. Cell Mol Immunol. 2018;15(3):289–291.
  • De Barrios O, Meler A, Parra M. MYC's fine line between B cell development and malignancy. Cells. 2020;9(2):523.
  • Rempel RE, Jiang X, Fullerton P, et al. Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic response. Mol Cancer Ther. 2014;13(12):3219–3229.
  • Lu ZP, Ju ZL, Shi GY, et al. Histone deacetylase inhibitor trichostatin a reduces anti-DNA autoantibody production and represses IgH gene transcription. Biochem Biophys Res Commun. 2005;330(1):204–209.
  • Saintamand A, Saad F, Denizot Y. 3'RR targeting in lymphomagenesis: a promising strategy? Cell Cycle. 2015;14(6):789–790.
  • Wourms MJ, Sulentic CEW. The aryl hydrocarbon receptor regulates an essential transcriptional element in the immunoglobulin heavy chain gene. Cell Immunol. 2015;295(1):60–66.
  • Snyder AD, Ochs SD, Johnson BE, et al. Aryl hydrocarbon receptor-induced activation of the human IGH hs1.2 enhancer: mutational analysis of putative regulatory binding motifs. Mol Immunol. 2020;120:164–178.
  • Dolloff NG. Discovery platform for inhibitors of IgH gene enhancer activity. Cancer Biol Ther. 2019;20(4):571–581.
  • Ghazzaui N, Ferrad M, Issaoui H, et al. HDAC recruitment in the IgH locus 3' regulatory region is different between mature B-cells and mature B-cell lymphomas. Leuk Lymphoma. 2021;62:3511–3515.